Key result
NSAID use in anticoagulated AF is linked to a preventable increase in bleeding risk.
Why the study?
Does intercurrent use of NSAIDs increase bleeding liability in patients with anticoagulated atrial fibrillation?
Does intercurrent use of NSAIDs increase bleeding liability in patients with anticoagulated atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Intercurrent use of NSAIDs in patients with anticoagulated atrial fibrillation represents a preventable bleeding liability.
Paschalis Karakasis, MD, PhD(c); Intercurrent NSAIDs in Anticoagulated Atrial Fibrillation: A Preventable Bleeding Liability, European Heart Journal - Qual
No takes yet. Share an insight, caveat, or question.
Paschalis Karakasis (2025) studied this question. Intercurrent use of non-steroidal anti-inflammatory drugs in patients with anticoagulated atrial fibrillation is associated with a preventable increase in bleeding risk.
Synapse has enriched 10 related papers. Consider them for comparative context: